Key facts
- This page summarizes Alphabet Inc.'s Form 4 filing for Oscar Health, Inc. (OSCR).
- 3 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 Aug 2023, 16:30.
Alphabet Inc. - 17 Aug 2023 Form 4 Insider Report for Oscar Health, Inc. (OSCR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- OSCR
- Reported as of
- 17 Aug 2023
- Net transaction value
- -$52,526,500
- Reporting owner signature
- /s/ Chris Rose, as attorney-in-fact for ALPHABET INC.
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Alphabet Inc. filed Form 4 for Oscar Health, Inc. (OSCR) on 21 Aug 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$52,526,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OSCR
transaction
Class A Common Stock
Sale
- Transaction value
- $46,218,778
- Shares
- -5,719,438
- Change %
- -27%
- Price
- $8.08
- Shares after
- 15,625,310
- Date
- 17 Aug 2023
- Ownership
- See footnote
- Footnotes
- F1, F2
OSCR
transaction
Class A Common Stock
Sale
- Transaction value
- $4,246,323
- Shares
- -525,470
- Change %
- -31%
- Price
- $8.08
- Shares after
- 1,180,474
- Date
- 17 Aug 2023
- Ownership
- See footnote
- Footnotes
- F1, F3
OSCR
transaction
Class A Common Stock
Sale
- Transaction value
- $2,061,398
- Shares
- -255,092
- Change %
- -100%
- Price
- $8.08
- Shares after
- 0
- Date
- 17 Aug 2023
- Ownership
- See footnote
- Footnotes
- F1, F4
OSCR
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 255,092
- Date
- 17 Aug 2023
- Ownership
- See footnote
- Footnotes
- F5
OSCR
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 481,988
- Date
- 17 Aug 2023
- Ownership
- See footnote
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 6 footnotes
Footnote F1
On August 17, 2023, (i) Alphabet Holdings LLC sold 5,719,438 shares of Class A Common Stock ("Common Shares"), (ii) CapitalG 2015 LP sold 525,470 Common Shares, and (iii) Verily Life Sciences LLC sold 255,092 Common Shares to an unaffiliated financial institution pursuant to a post-paid forward transaction at a price based on the volume weighted average price of the Common Shares over a period of time determined by the financial institution, subject to an agreed minimum and maximum period.
Footnote F2
These shares are owned directly by Alphabet Holdings LLC. XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of XXVI Holdings Inc. and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
Footnote F3
These shares are owned directly by CapitalG 2015 LP. CapitalG 2015 GP LLC, the general partner of CapitalG 2015 LP, Alphabet Holdings LLC, the managing member of CapitalG 2015 GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG 2015 GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
Footnote F4
These shares are owned directly by Verily Life Sciences LLC. OB Technology Holdings Inc., the managing member of Verily Life Sciences LLC, XXVI Holdings Inc., the managing member of OB Technology Holdings Inc., and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of OB Technology Holdings Inc., XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
Footnote F5
These shares are owned directly by CapitalG LP. CapitalG GP LLC, the general partner of CapitalG LP, Alphabet Holdings LLC, the managing member of CapitalG GP LLC, XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of CapitalG GP LLC, Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.
Footnote F6
These shares are owned directly by GV 2014, L.P. GV 2014 GP, L.L.C., the general partner of GV 2014, L.P., Alphabet Holdings LLC, the managing member of GV 2014 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the controlling stockholder of XXVI Holdings Inc., may each be deemed to have sole voting and dispositive power with respect to these shares. Each of GV 2014 GP, L.L.C., Alphabet Holdings LLC, XXVI Holdings Inc., and Alphabet Inc. disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein.